Leadership Team

Picture of RenovoRx CEO, Shaun R. Bagai
Shaun R. Bagai
Chief Executive Officer

Shaun R. Bagai

Chief Executive Officer

Mr. Bagai has served as our Chief Executive Officer and director since June 2014. Prior to joining us, Mr. Bagai led Global Market Development for HeartFlow, Inc. from 2011 to 2014, which included directing Japanese market research, regulatory/payer collaboration, and Key Opinion Leader development to create value resulting in a company investment to form HeartFlow-Japan. During his tenure at HeartFlow, he successfully orchestrated their largest clinical trial to date and contracted HeartFlow’s first global customers. In addition, Mr. Bagai has launched innovative technologies into regional and global marketplaces in both large corporations and growth-phase novel technology companies. He was instrumental in developing the European market for renal denervation for the treatment of hypertension leading to the acquisition of the first renal denervation company — Ardian, Inc. by Medtronic in 2011. Mr. Bagai is a graduate from the University of California, Santa Barbara with a BSc. in Biology/Pre-Med.

Picture of RenovoRx, Chief Medical Officer and Co-FounderRamtin Agah, MD
Ramtin Agah, MD
Chief Medical Officer, Founder

Ramtin Agah, MDRamtin Agah, MD

Chief Medical Officer, Founder

Dr. Agah has served as our Chief Medical Officer and Co-Founder since December 2009, and as Chairman of the Board since May 2018. Dr. Agah is currently an Interventional Cardiologist at El Camino Hospital, Mountain View, a role he began in September 2005. He also has acted as a physician consultant for Abbott Vascular since July 2012. Previously, Dr. Agah was an Assistant Professor of Internal Medicine with the Division of Cardiology, University of Utah. Dr. Agah completed a Fellowship in Interventional Cardiology with Cleveland Clinic Foundation, a Residency in Internal Medicine with Baylor College of Medicine and a Fellowship in Cardiology with University of California, San Francisco. He received his MD from the University of Texas Southwestern Medical School.

Headshot - Angela Gill Nelms
Angela Gill Nelms
Chief Operating Officer

Angela Gill NelmsAngela Gill Nelms

Chief Operating Officer

Ms. Nelms is an accomplished leader with diverse experience including as a company founder, entrepreneur, board member, research professional, medical device technologist, and educator. She previously served as COO at Florence Healthcare, a company that streamlines clinical trial management through web-based solutions. As COO, Ms. Nelms led operational and product direction for the company and grew the business to support more than 10,000 clinical researchers in 44 countries. Additionally, during her tenure, the company grew from four to over 100 employees. Ms. Nelms earned a Bachelor of Science in Biomedical Engineering from the College of Engineering at the Georgia Institute of Technology. In April 2022, she was inducted into the College’s Academy of Distinguished Engineering Alumni.

Headshot - Leesa Gentry
Leesa Gentry
Senior Vice President of Clinical Operations

Leesa GentryLeesa Gentry

Senior Vice President of Clinical Operations

Ms. Gentry brings 29 years of experience focused on improving clinical research programs in Contract Research Organization (CRO), pharmaceutical, and biotech industries. Past employers include IQVIA (Quintiles), PPD, OmnicareCR and Otsuka. Prior to RenovoRx, she was Senior Vice President (SVP) of Clinical Operations at Evotec. (NASDAQ: EVO). At PPD, Ms. Gentry was Global Project Manager and Senior Research Specialist for Clinical Systems where her team developed one of the pharmaceutical industry’s first clinical trial management systems.

At Omnicare, Ms. Gentry grew the clinical research site network within long-term care; her work was featured in the Good Clinical Practice Journal. During her tenure at Otsuka, Ms. Gentry developed novel methods for improved, streamlined trial implementation in clinical operations, data management and third-party collaboration. Her work on registration trial implementation within resource-constrained environments was featured in the Bulletin of the World Health Organization. Ms. Gentry holds a B.A. in Psychology and M.S. in Gerontology from the University of Central Missouri, and an M.A. of Psychology from the University of Mary Hardin-Baylor.

Ronald B. Kocak, CPA
Vice President, Controller & Principal Financial Officer

Ronald B. Kocak, CPARonald B. Kocak, CPA

Vice President, Controller & Principal Financial Officer

Mr. Kocak is a seasoned financial reporting and accounting professional with extensive public company experience in the life sciences industry. Mr. Kocak has served as RenovoRx’s interim controller in a consulting capacity since October 2021. Prior to joining RenovoRx, Mr. Kocak was Controller and Senior Director of Finance at Sensei Biotherapeutics, Inc., where he successfully led the finance and accounting activities, including the IT operations. He holds a Bachelor of Science in accounting from Duquesne University and a CPA license in the Commonwealth of Virginia. Mr. Kocak is also a member of the American Institute of Certified Public Accountants and Association of Bioscience Financial Officers, and a Chartered Global Management Accountant.

RenovoRx Director of Imaging, Imtiaz Qureshi, MD
Imtiaz Qureshi, MD
Director of Imaging

Imtiaz Qureshi, MDImtiaz Qureshi, MD

Director of Imaging

Dr. Qureshi went to the prestigious Aga Khan University School of Medicine and graduated with honors. He completed a post-doctoral Fellowship in Molecular Biology and Physiology at Yale University. He completed an internship at Yale School of Medicine in General Surgery and subsequently joined Hartford Hospital for Diagnostic Radiology Residency. He was the Chief Resident during his Residency. Subsequently, he went to Stanford University where he completed a Fellowship in Neuroradiology. He is currently at El Camino Hospital where he has been the Medical Director and Chief of Radiology for the last 10 years.

Dr. Qureshi’s research interests include Artificial Intelligence and Machine Learning in Imaging. He serves as an adviser to several keys companies developing new imaging platforms for Breast Imaging, Neuroimaging and Oncologic Imaging using Artificial Intelligence.